Walleye Capital’s Exascale Labs Holdings Inc. Warrant XLABW Stock Holding History

Walleye Capital’s Portfolio XLABW Stock Details XLABW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16K	Buy	+100,000	New	+$29.8K	﹤0.01%	5690

Other funds holding XLABW

PEAK6 Chicago, Illinois $54.8B AUM 16.89% 1-Year Est. Return

OMERS Administration Corp Toronto, Ontario, Canada $16.3B AUM 28.35% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

DLD Asset Management New York $1.44B AUM 3.08% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Walleye Capital's XLABW Position: Q3 2026 in Review

Walleye Capital opened a new position in Exascale Labs Holdings Inc. Warrant (XLABW) in Q3 2026: 100,000 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #5690 among its holdings.

14 funds tracked by Wall St. Rank hold XLABW as of Q3 2026.

Walleye Capital held 100,000 shares of Exascale Labs Holdings Inc. Warrant worth $16K as of Q3 2026.
Exascale Labs Holdings Inc. Warrant was a new Walleye Capital position in Q3 2026.
Exascale Labs Holdings Inc. Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5690 holding.
14 funds tracked by Wall St. Rank held Exascale Labs Holdings Inc. Warrant as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.